Fred Binka
Direttore/Membro del Consiglio presso International Vaccine Institute
Provenienza dei contatti di primo grado di Fred Binka
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Malaria Consortium
 Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson.
15
| Non-Profit Organization | Medical/Nursing Services | 15 |
International Vaccine Institute
 International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015.
8
| Non-Profit Organization | Miscellaneous Commercial Services | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Fred Binka tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BECTON, DICKINSON AND COMPANY | Medical Specialties | Director/Board Member | |
Foundation for Innovative New Diagnostics
 Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Director/Board Member | |
| Medical University of Vienna | College/University | Corporate Officer/Principal | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Private Equity Investor | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Doctorate Degree | |
| McGill University | College/University | Doctorate Degree | |
| University of London | College/University | Graduate Degree | |
| The Pennsylvania State University | College/University | Graduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
| University of Vienna | College/University | Doctorate Degree | |
| University of Mumbai | College/University | Doctorate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| University of Basel | College/University | Corporate Officer/Principal | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal | |
| Bishop's University | College/University | Undergraduate Degree | |
| University of Santo Tomas | College/University | Undergraduate Degree | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Siena | College/University | Graduate Degree | |
MassBiologics
 MassBiologics BiotechnologyHealth Technology Part of University of Massachusetts, Inc., MassBiologics is a company that aims to improve public health by discovering and developing products. The company is based in Mattapan, MA. The company's focus is on creating products for smaller patient populations, uncertain markets, and developing nations with limited resources and unique needs. | Biotechnology | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
Drugs for Neglected Diseases initiative
 Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member | |
| University of Perpetual Help System Dalta | College/University | Doctorate Degree | |
GlaxoSmithKline Pte Ltd.
 GlaxoSmithKline Pte Ltd. Pharmaceuticals: OtherHealth Technology GlaxoSmithKline Pte Ltd. engages in pharmaceutical products. It provides prescription medicines, vaccines, and consumer healthcare services. The company is headquartered in Gateway West, Singapore. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman | |
Universitätsspital Basel
 Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | Hospital/Nursing Management | Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member | |
| Global Agenda Council | Corporate Officer/Principal | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Affinivax, Inc.
 Affinivax, Inc. BiotechnologyHealth Technology Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA. | Biotechnology | Director/Board Member | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Private Equity Investor | |
| Clearpath Vaccines Co. | Chief Tech/Sci/R&D Officer | ||
| African Research Excellence Fund | Director/Board Member | ||
Meininger Verlag GmbH
 Meininger Verlag GmbH Publishing: Books/MagazinesConsumer Services Meininger Verlag GmbH provides the latest news and tasting results from the wine and beverage industry. The private company is based in Neustadt, Germany. The German company offers information on the best wines, beers, and spirits. The CEOs are Wolfgang Heckmann, Horst Emmert, Ralf Clemens. The company was founded in 1903 by Daniel Meininger. | Publishing: Books/Magazines | Chief Executive Officer | |
Baobab Circle Ltd.
 Baobab Circle Ltd. Packaged SoftwareTechnology Services Baobab Circle Ltd. develops artificial intelligence based mobile application to manage diabetes and hypertension. It offers Afya Pap has a wide range of useful functionality to help users to tackle their condition. The company was founded by Precious Lunga and George Franklin on May 31, 2013 and is headquartered in London, the United Kingdom. | Packaged Software | Founder | |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
| Wyeth Vaccines Research | Chief Tech/Sci/R&D Officer | ||
Tiba Biotech LLC
 Tiba Biotech LLC BiotechnologyHealth Technology Tiba Biotech LLC is a company that specializes in advancing the RNA medicine field with an improved approach to nucleic acid delivery. The company is based in Cambridge, MA. The company has developed a fully biodegradable nanoparticle delivery platform for safer vaccines and therapeutics, as well as a computational RNA design for more potent gene expression. The company's goal is to achieve better patient outcomes through rational design, from gene to delivery method beyond vaccines. The company was founded in 2017 by Christian Mandl, Karl H. Ruping, Jasdave Chahal. Karl H. Ruping has been the CEO since 2017. | Biotechnology | Founder | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member | |
| LAKESHORE BIOPHARMA CO., LTD | Biotechnology | Chief Tech/Sci/R&D Officer | |
Mindfactory AG
 Mindfactory AG Electronics DistributorsDistribution Services Mindfactory AG is an online retailer that specializes in selling a wide range of hardware, software, notebooks, computers, tablets, smartphones, and game consoles. The private company was founded in 1996 and is based in Wilhelmshaven, Germany. | Electronics Distributors | Chairman |
Statistiche
Distribuzione geografica
| Stati Uniti | 18 |
| Svizzera | 8 |
| Germania | 6 |
| Austria | 4 |
| Regno Unito | 4 |
Settori
| Health Technology | 21 |
| Consumer Services | 19 |
| Health Services | 4 |
| Technology Services | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 60 |
| Corporate Officer/Principal | 25 |
| Independent Dir/Board Member | 13 |
| Doctorate Degree | 10 |
| Chairman | 10 |
Contatti più connessi
| Insiders | |
|---|---|
| George Bickerstaff | 37 |
| Adel Mahmoud | 17 |
| George Siber | 14 |
| Ralf Clemens | 14 |
| J. Kim | 11 |
| Christian Mandl | 9 |
| Zenaida Mojares | 8 |
| Marcel Tanner | 7 |
| Nermeen Varawalla | 7 |
| Jerome H. Kim | 2 |
| Precious Lunga | 2 |
| Charles Nelson | 1 |
| Canisius Anthony | 1 |
| Brian Greenwood | 1 |
| Peter Potter-Lesage | 1 |
- Borsa valori
- Insiders
- Fred Binka
- Connessioni Società
